From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
Tumor
Number of patient tumors
Average yield (and range) or TILs from pre-REP (106)
Bladder
2
290 (97-600)
Cervical
4
360 (147-800)
H&N
7
539 (132-738)
Lung
8
688 (50-915)
TNBC
13
429 (81-665)